Cerebral Venous Sinus Thrombosis After Translabyrinthine Vestibular Schwannoma-A Prospective Study and Suggested Management Paradigm.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 11 12 2019
medline: 15 4 2021
entrez: 11 12 2019
Statut: ppublish

Résumé

To prospectively evaluate the incidence, risk factors and natural history of postoperative cerebral venous sinus thrombosis (pCVST) in translabyrinthine vestibular schwannoma microsurgical resection and propose a potential management paradigm. Prospective, single cohort, multicenter study. State-wide academic tertiary referral centers. Fifty-four consecutive patients who underwent translabyrinthine vestibular schwannoma resection. Incidence of pCVST on postoperative imaging on Day 7, Day 28, and 12 months postoperatively. Patients and tumor characteristics, risk factors, length of stay, intraoperative parameters, complications, and follow-up were analyzed. pCVST was demonstrated in 21 patients (38.9%) on postoperative imaging. All patients with pCVST were treated conservatively and remained asymptomatic in the immediate postoperative period and long-term follow-up. There were no instances of venous infarction, intracranial hemorrhage, or neurological deficits. A majority (61.1%) of pCVST recannalised on long-term follow up with conservative management. There was a statistical association with pCVST and surgery on the side of the non-dominant cerebral venous drainage (n = 17, 80.1%, p = 0.034). Patients with pCVST were significantly more likely to have a postoperative cerebrospinal fluid (CSF) leak (n = 5, 23.8%, p = 0.017). The incidence of pCVST following translabyrinthine vestibular schwannoma resection is much higher than previously recognized. pCVST is more likely to occur when surgery is performed on tumors situated on the side of non-dominant cerebral venous drainage. Despite the high prevalence of this iatrogenic phenomenon, all patients were asymptomatic and a majority resolved, thereby suggesting that conservative management is safe. Correlation between pCVST and increased incidence of CSF leak requires further investigation.

Identifiants

pubmed: 31821255
doi: 10.1097/MAO.0000000000002508
pii: 00129492-202002000-00037
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e273-e279

Références

Abou-Al-Shaar H, Gozal T, Alzhrani G, et al. Cerebral venous sinus thrombosis after vestibular schwannoma surgery: a call for evidence-based management guidelines. Neurosurg Focus 2018; 45:E4.
Apra C, Kotbi O, Turc G, et al. Presentation and management of lateral sinus thrombosis following posterior fossa surgery. J Neurosurg 2017; 126:8–16.
Keiper GL Jr, Sherman J, Tomsick T, et al. Dural sinus thrombosis and pseudotumor cerebri: unexpected complications of suboccipital craniotomy and translabyrinthine craniectomy. J Neurosurg 1999; 91:192–197.
Moore J, Thomas P, Cousins V, et al. Diagnosis and management of dural sinus thrombosis following resection of cerebellopontine angle tumors. J Neurol Surg B Skull Base 2014; 75:402–408.
Benjamin CG, Sen R, Golfinos J, et al. Postoperative cerebral venous sinus thrombosis in the setting of surgery adjacent to the major dural venous sinuses. J Neurosurg 2018; 1–7.
Medel R, Monteith S, Crowley R, et al. A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurg Focus 2009; 27:E6.
Sader N, de Lotbiniere-Bassett M, Tso M, et al. Management of venous sinus thrombosis. Neurosurg Clin N Am 2018; 29:585–594.
Coutinho J, de Bruijn S, Deveber G, et al. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011; Cd002005.
Ferro JM, Bousser M, Canhao P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol 2017; 24:1203–1213.
Koos WT, Day J, Matula C, et al. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 1998; 88:506–512.
Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 1995; 113:179–180.
Kanzaki J, Tos M, Sanna M, et al. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003; 24:642–648. discussion 648–9.
Bowman J. The translabyrinthine approach. Operat Tech Otolaryngol Head Neck Surg 2013; 24:149–156.
Ohata K, Haque M, Morino M, et al. Occlusion of the sigmoid sinus after surgery via the presigmoidal-transpetrosal approach. J Neurosurg 1998; 89:575–584.
Mizutani K, Akiyama T, Yoshida K, et al. Skull base venous anatomy associated with endoscopic skull base neurosurgery: a literature review. World Neurosurg 2018; 120:405–414.
Glik A, Benkovich E, Kesler A, et al. Lateral sinus thrombosis: the importance of the unaffected sinus. J Neuroimaging 2016; 26:599–604.
Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974; 97:301–312.
Karahalios DG, Rekate H, Khayata M, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996; 46:198–202.
Saposnik G, Barinagarrementeria F, Brown R, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:1158–1192.

Auteurs

Emily Guazzo (E)

Department of Otolaryngology, Head and Neck Surgery, Ipswich Hospital.
Queensland Skull Base Unit, Princess Alexandra Hospital.
Faculty of Medicine, University of Queensland.

Benedict Panizza (B)

Department of Otolaryngology, Head and Neck Surgery.
Queensland Skull Base Unit, Princess Alexandra Hospital.
Faculty of Medicine, University of Queensland.
Brisbane Clinical Neurosciences Centre, Mater Hospital, Brisbane, Australia.

Andrew Lomas (A)

Queensland Skull Base Unit, Princess Alexandra Hospital.
Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital.
Faculty of Medicine, University of Queensland.
Brisbane Clinical Neurosciences Centre, Mater Hospital, Brisbane, Australia.

Martin Wood (M)

Queensland Skull Base Unit, Princess Alexandra Hospital.
Brisbane Clinical Neurosciences Centre, Mater Hospital, Brisbane, Australia.

Damien Amato (D)

Department of Neurosurgery.
Queensland Skull Base Unit, Princess Alexandra Hospital.
Brisbane Clinical Neurosciences Centre, Mater Hospital, Brisbane, Australia.

Andrew Alalade (A)

Department of Neurosurgery, The Walton Centre NHS Foundation Trust Liverpool, United Kingdom.

Mitesh Gandhi (M)

Department of Radiology.
Queensland Skull Base Unit, Princess Alexandra Hospital.

James Bowman (J)

Department of Otolaryngology, Head and Neck Surgery.
Brisbane Clinical Neurosciences Centre, Mater Hospital, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH